Stay updated on Pimavanserin Safety in Neurodegenerative Disease Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page.

Latest updates to the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page
- Check3 days agoChange DetectedThe page’s interface revision identifier was updated from v3.5.2 to v3.5.3, reflecting a minor site/UI release without changing the underlying record history content.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded revision: v3.5.2 to the history. Removed revision: v3.5.0 from the history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision v3.5.0 was added to the history and revision v3.4.3 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision history updated: Revision v3.4.3 was added and Revision v3.4.2 was removed.SummaryDifference0.1%

- Check74 days agoChange DetectedAdministrative site updates: a new Revision: v3.4.2 was added and a prior Revision: v3.4.1 notice was removed, along with deletion of government funding/operating status notices; there are no changes to study data, status, or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check82 days agoChange DetectedRevision: v3.4.1 is now shown, replacing v3.4.0, and a general notice about government funding updates the page header. These are administrative updates and do not modify the study data or its history on this page.SummaryDifference0.6%

Stay in the know with updates to Pimavanserin Safety in Neurodegenerative Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Safety in Neurodegenerative Disease Clinical Trial page.